| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |